Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Manoj Mathew

Pulmonary Disease Phoenix, AZ Medical Doctor

NPI 1467572107 CMS profile 21624

3811 E Bell Rd Ste 107, Phoenix, AZ 85032

Open in the dashboard

General payments

$17,736

184 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Manoj Mathew of Phoenix, AZ is reported in the CMS Open Payments database as having received $17,736 across 184 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 88th percentile of Pulmonary Disease profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,378 3
2024 General $19 1
2023 General $1,649 7
2022 General $23 1
2021 General $247 13
2020 General $3,177 57
2019 General $8,243 102

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Manoj Mathew
  • Pulmonary Disease median
  • Middle half of Pulmonary Disease
  • National median

In program year 2025, general payments to Manoj Mathew were reported at $4,378. Among 8,914 Pulmonary Disease profiles paid that year, the median was $500 and the middle half received between $124 and $1,893.

Show as a table
Year Manoj Mathew Pulmonary Disease median Middle half National median
2019 $8,243 $377 $109–$1,340 $163
2020 $3,177 $230 $56–$907 $114
2021 $247 $269 $68–$1,072 $132
2022 $23 $390 $100–$1,457 $149
2023 $1,649 $419 $114–$1,659 $160
2024 $19 $476 $123–$1,818 $164
2025 $4,378 $500 $124–$1,893 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AstraZeneca Pharmaceuticals LP $9,002 47 payments
  2. Intuitive Surgical, Inc. $4,378 3 payments
  3. Medical Device Business Services, Inc. $1,587 5 payments
  4. Stryker Corporation $500 1 payment
  5. Boehringer Ingelheim Pharmaceuticals, Inc. $375 18 payments
  6. GlaxoSmithKline, LLC. $265 18 payments
  7. Sunovion Pharmaceuticals Inc. $205 17 payments
  8. Philips Electronics North America Corporation $168 8 payments
  9. Mylan Specialty L.P. $136 7 payments
  10. Jazz Pharmaceuticals Inc. $124 6 payments
  11. Other $996 54 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $7,750 6 payments
  2. Education $4,000 2 payments
  3. Food and Beverage $3,196 168 payments
  4. Travel and Lodging $2,290 7 payments
  5. Consulting Fee $500 1 payment
Products named General payments · program years 2019–2025
  1. FASENRA $8,739 28 payments
  2. Da Vinci Surgical System $4,378 3 payments
  3. Monarch $1,587 5 payments
  4. GLIDE SYSTEM $500 1 payment
  5. SYMBICORT $247 16 payments
  6. SPIRIVA RESPIMAT $231 14 payments
  7. OFEV $207 9 payments
  8. LONHALA MAGNAIR $170 15 payments
  9. Yupelri $136 7 payments
  10. NUCALA $129 8 payments
  11. Other $2,145 120 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

184 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pulmonary Disease in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record